Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
CrossRef Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis Yun Su, Tongze Cai, Jingxuan Wei, Qiuju Huang, Chun Yao, Lei Fu, Jinghui Zheng, Hongwei Guo, Xiongbin Gui Frontiers in Immunology .2026;[Epub] CrossRef National and regional lifetime risks of developing and dying from digestive system cancers in China: Findings of the Global Burden of Disease Study 2023 Qian Mao, Zhenping Zhao, Jiangmei Liu, Yuchang Zhou, Maigeng Zhou Chinese Medical Journal .2026;[Epub] CrossRef Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024 Subin Heo, Yong Jun Jung, Eun Sun Choi, Sehee Kim, Kyoung Won Kim, Young-In Yoon, Hyung Jin Won, Yong Moon Shin, Dong Hwan Kim, Sang Hyun Choi Radiology .2026;[Epub] CrossRef RealWorld Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study Dinghu Zhang, Qinfen Xie, Zhewei Zhang, Song Wang, Jibing Liu, Xiang An, Kangshou Liu, Zhengping Yu, Huiling Xiang, Qiang He, Xin Zheng, Zukuan Chang, Ruijie Du, Li Zhang, Gong Li, Qingyu Xu, Wenjie Song, Bin Jin, Chongzhong Liu, Jianjun Li, Xu Zhou, Wenb International Journal of Cancer .2026;[Epub] CrossRef Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (510 cm) versus Giant (10 cm) Hepatocellular Carcinoma: A Retrospective Study Kunyuan Jiang, Jingfei Li, Dongli Zhang, Weiping Wang, Jun Chang Journal of Hepatocellular Carcinoma .2026
Protein intake requirements Protein becomes even more important during peptide-supported weight loss
It happens when a protein called transthyretin builds up in the heart muscle
(2024) 10:e25680
At three months, researchers found that participants who received semaglutide had a decreased risk for major adverse cardiovascular events (MACE), which included non-fatal heart attack, non-fatal stroke, or cardiovascular death
